Gentium (GENT)
Create an AlertGentium Valuation Percentage
Gentium Valuation Percentage Chart
View Valuation Percentage for GENT.
Start Your YCharts Pro Gold Membership.
Gentium Historical Valuation Percentage Data
Pro Data ExportThere is no data for the selected date range.
About Valuation Percentage
Click the "Learn More" link below to see how the valuation percentage is calculated.
The valuation percentage shows how far above or below its historical valuation levels the stock currently is. It takes into account a long-term average of the Price to Sales Ratio and Price to Earnings Ratio and mathematically determines whether the current price is high or low relative to those historic valuation multiples.
It is important to note that this is not a measurement of how the stock's price relates to its "intrinsic value", but is instead a measurement of how the market is valuing the stock relative to how it was valued historically.
Learn More
View Valuation Percentage for GENT.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
GENT Valuation Percentage Benchmarks
| Companies | |
|---|---|
| Salix Pharmaceuticals | Go Pro |
| Takeda Pharmaceutical | Go Pro |
| BioTech Medics | Go Pro |
GENT Valuation Percentage Rankings
| Overall |
95th percentile 691 of 16770 |
| Sector |
95th percentile 64 of 1408 in Healthcare |
| Industry |
96th percentile 6 of 152 in Drug Manufacturers - Specialty & Generic |
GENT Valuation Percentage Range, Past 5 Years
| Minimum | Go Pro | Jun 2012 |
| Maximum | Go Pro | Sep 2011 |
| Average | Go Pro |